Maddocks boasts a notable practice with capabilities to handle a wide range of IP matters. It provides particular strength in patents, acting on licensing agreements and commercialisation as well as substantial litigation proceedings in the pharmaceutical, medical technology and chemical engineering industries. It also offers expertise on an array of trade mark-related legal services, including portfolio management, licensing, brand acquisitions and oppositions. Additionally, Maddocks is active on copyright enforcement matters. Notable clients include Aristocrat Technologies and Sydney Airport Corporation.

Maddocks acted for Pharmacor in the Federal Court, defending proceedings brought by Novartis for alleged infringement of four patents for certain formulations and uses of fingolimod, sold by Novartis as its blockbuster drug Gilenya for multiple sclerosis. Pharmacor cross-claimed seeking revocation of the patents.

Ben Miller has a well-established reputation in the patent litigation space, where he frequently acts for big-name clients in the pharmaceutical and biotechnological sectors. ''He's a very calm lawyer when he's dealing with clients. He can categorically analyse things and provide you with a clear explanation.''